National Hospital Organization Kumamoto Medical Center
Chuo-ku, Kumamoto, 860-0008, Japan
NCT Number: NCT01098786
This is to evaluate safety of cell-derived A/H1N1 influenza HA vaccine in healthy Japanese subjects.
Looking for future studies?
Notify MeAll sexes
Observational
Chuo-ku, Kumamoto, 860-0008, Japan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The person is regarded as a subject in one of the following items 3) to 6) who is not appropriate to receive preventive vaccination as described in the current package insert.
Single group vaccinated
Time frame: 28 days
Time frame: 28 days
Novartis Vaccines
Industry
Observational Study to Evaluate Safety of Cell-derived A/H1N1 Influenza HA Vaccine in Healthy Japanese Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01069367
Swine-Origin Influenza A H1N1 Virus
Kagoshima, Japan
View Trial DetailsNCT01000207
Swine-Origin Influenza A H1N1 Virus
Kagoshima, Japan
View Trial Details